Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 18Breast Neoplasms 15Endometrial Neoplasms 11Uterine Cervical Neoplasms 5Carcinoma, Ovarian Epithelial 5Triple Negative Breast Neoplasms 4Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Neoplasms by Site 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Breast Diseases 3Uterine Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Hereditary Sensory and Autonomic Neuropathies 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Endometrial Stromal 1Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Recurrence 1Pancreatic Neoplasms 1Liposarcoma 1Genital Neoplasms, Female 1

Interventions

Specimen Handling 6Paclitaxel 6Magnetic Resonance Spectroscopy 5Nivolumab 4Carboplatin 4Biopsy 4pembrolizumab 2olaparib 2ceralasertib 2Taxes 2trastuzumab deruxtecan 1sargramostim 1rucaparib 1ribociclib 1rebastinib 1pelcitoclax 1pamiparib 1durvalumab 1cobimetinib 1cediranib 1cabozantinib 1belinostat 1atezolizumab 1X-Rays 1Tissue Banks 1TIC10 compound 1Ipilimumab 1Immunoglobulin G 1Ifosfamide 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinosarcoma × Fulvestrant × Gynecologic × Clear all
NCT05252416 2025-11-28

(VELA) Study of BLU-222 in Advanced Solid Tumors

Blueprint Medicines Corporation

Phase 1 Terminated
50 enrolled
GastrointestinalGynecologicSarcoma

Adenocarcinoma Of Esophagus, Carcinosarcoma, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡